ViroGates A/S (VIRO) - Total Liabilities

Latest as of March 2026: Dkr9.98 Million DKK ≈ $1.56 Million USD

Based on the latest financial reports, ViroGates A/S (VIRO) has total liabilities worth Dkr9.98 Million DKK (≈ $1.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital to net assets of ViroGates A/S to evaluate short-term liquidity relative to the company's equity base.

ViroGates A/S - Total Liabilities Trend (2015–2025)

This chart illustrates how ViroGates A/S's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ViroGates A/S asset portfolio.

ViroGates A/S Competitors by Total Liabilities

The table below lists competitors of ViroGates A/S ranked by their total liabilities.

Company	Country	Total Liabilities
DELPHI WORLD MONEY LIMITED NSE:DELPHIFX	India	Rs5.17 Billion
Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares NASDAQ:AHMA	USA	$3.58 Million
SDN Company. Ltd KQ:099220	Korea	₩83.71 Billion
T3 Defense Inc. NYSE:DFNS	USA	$98.39 Million
Aurora Labs Ltd AU:A3D	Australia	AU$1.84 Million
Air Industries Group NYSE MKT:AIRI	USA	$39.11 Billion
Vakif Menkul Kiymet Yatirim Ortakligi AS IS:VKFYO	Turkey	TL2.05 Million
Glennon Small Companies Ltd AU:GC1	Australia	AU$5.88 Million

Liability Composition Analysis (2015–2025)

This chart breaks down ViroGates A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ViroGates A/S (VIRO) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.82	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.59	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ViroGates A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ViroGates A/S (2015–2025)

The table below shows the annual total liabilities of ViroGates A/S from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	Dkr11.19 Million ≈ $1.75 Million	+62.94%
2024-12-31	Dkr6.87 Million ≈ $1.07 Million	-9.05%
2023-12-31	Dkr7.55 Million ≈ $1.18 Million	+420.19%
2022-12-31	Dkr1.45 Million ≈ $227.02K	-61.85%
2021-12-31	Dkr3.80 Million ≈ $595.01K	-45.14%
2020-12-31	Dkr6.93 Million ≈ $1.08 Million	+135.62%
2019-12-31	Dkr2.94 Million ≈ $460.30K	+21.97%
2018-12-31	Dkr2.41 Million ≈ $377.37K	+21.76%
2017-12-31	Dkr1.98 Million ≈ $309.94K	-34.23%
2016-12-31	Dkr3.01 Million ≈ $471.25K	-0.46%
2015-12-31	Dkr3.03 Million ≈ $473.44K	--

About ViroGates A/S

CO:VIRO Denmark Medical Devices

Market Cap

$14.67 Million

Dkr93.75 Million DKK

Market Cap Rank

#26151 Global

#119 in Denmark

Share Price

Dkr10.10

Change (1 day)

-5.61%

52-Week Range

Dkr9.05 - Dkr17.40

All Time High

Dkr238.00